本頁面由Tiger Trade Technology Pte. Ltd.提供服務

GT Biopharma Inc.

8.61
+2.4339.32%
盤後8.680.0700+0.81%19:57 EDT
成交量:54.43萬
成交額:439.90萬
市值:1,553.57萬
市盈率:-0.65
高:8.82
開:6.59
低:6.59
收:6.18
52周最高:34.25
52周最低:4.91
股本:180.44萬
流通股本:170.06萬
量比:5.90
換手率:32.00%
股息:- -
股息率:- -
每股收益(TTM):-13.2195
每股收益(LYR):-156.2099
淨資產收益率:-113.52%
總資產收益率:-158.16%
市淨率:4.35
市盈率(LYR):-0.06

資料載入中...

2025/02/07

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

重要事件披露

Form 8-K - Current report
2024/12/23

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/28

重要事件披露

Form 8-K - Current report
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/27

SEC問詢函

Form CORRESP - Correspondence
2024/06/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/20

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/23

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]